Abstract: A liquid crystal cell includes substrates defining a gap and electrodes having one of (i) an in-plane geometry generating an electric field parallel with the substrates and (ii) a top-down geometry generating an electric field across the gap between the two spaced apart substrates. A liquid crystal material disposed in the gap between the substrates comprises a chiral nematic material formed by a mixture of: 1-(4-cyanobiphenyl-4?-yl)-6-(4-cyanobiphenyl-4?-yloxy)hexane (CB6OCB) or ?,?-bis(4,4-cyanobiphenyl)nonane (CB9CB) dimeric liquid crystal material; at least one additional dimeric liquid crystal material; and a chiral dopant.
Type:
Grant
Filed:
February 25, 2016
Date of Patent:
August 15, 2017
Assignees:
KENT STATE UNIVERSITY, THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN
Inventors:
Oleg D. Lavrentovich, Jie V. Xiang, Sergij V. Shiyanovskii, Corrie T. Imrie, Daniel A. Paterson, John M. Storey
Abstract: A system and method for determining a remaining processing capacity of a scrubber having a flow path and a processing material disposed along the flow path. A device may comprise a plurality of optical sensors disposed within the processing material and arranged along the flow path, a light source, and a processor for determining the capacity according to signals received from the optical sensor. The device may be used to illuminate processing material adjacent to each optical sensor using the light source, measure a light value reflected by the processing material at each optical sensor, and determine the remaining processing capacity of the scrubber, using the processor, based on the measured light value. Devices may comprise a memory, such as a non-volatile memory to allow multiple uses of a scrubber without reloading with fresh processing material.
Type:
Grant
Filed:
April 6, 2012
Date of Patent:
August 15, 2017
Assignee:
The Research Foundation for The State University of New York
Inventors:
Clas Erik Gunnar Lundgren, Ronald M. Okupski
Abstract: A method is provided for fabricating a graphene-doped, carbohydrate-derived hard carbon (G-HC) composite material for alkali metal-ion batteries. The method provides graphene oxide (GO) dispersed in an aqueous solution. A carbohydrate is dissolved into the aqueous solution and subsequently the water is removed to create a precipitate. In one aspect, the carbohydrate is sucrose. The precipitate is dehydrated and exposed to a thermal treatment of less than 1200 degrees C. to carbonize the carbohydrate. The result is the formation of a graphene-doped, carbohydrate-derived hard carbon (G-HC) composite. Typically, the G-HC composite is made up of graphene in the range of 0.1 and 20% by weight (wt %), and HC in the range of 80 to 99.9 wt %. The G-HC composite has a specific surface area of less than 10 square meters per gram (m2/g). A G-HC composite suitable for use in alkali metal-ion batteries electrodes is also provided.
Type:
Grant
Filed:
June 5, 2015
Date of Patent:
August 15, 2017
Assignees:
Oregon State University, Sharp Laboratories of America
Inventors:
Xiulei Ji, Wei Luo, Clement Bommier, Yuhao Lu, Sean Vail, Jong-Jan Lee
Abstract: This disclosure relates generally to computerized systems and methods of producing a physical representation of an in silico Integrated Circuit (IC) having an in silico Multi-Mode Redundant (MMR) pipeline circuit. An IC layout of the in silico IC is initially generated with the electronic design automation (EDA) program. Multi-Mode Redundant Self-Correcting Sequential State Element (MMRSCSSE) layouts are then rendered immotile while initial redundant Combinational Logic Circuit (CLC) layouts are removed from the IC layout after the MMRSCSSE layouts have been rendered immotile. By first placing the MMRSCSSE layouts and then rendering them immotile, the remaining logic can be placed again and optimized without compromising critical node spacing. As such, the described method provides for a more efficient way to create the IC layout of the in silico IC while maintaining critical node spacing.
Type:
Grant
Filed:
June 15, 2015
Date of Patent:
August 15, 2017
Assignee:
Arizona Board of Regents on behalf of Arizona State University
Inventors:
Lawrence T. Clark, Dan Wheeler Patterson, Chandarasekaran Ramamurthy, Srivatsan Chellappa
Abstract: The present invention provides a diagnostic reagent or assay for assessing the activity of a protease in vivo or in vitro and methods of detecting the presence of a cancerous or precancerous cell. The assays are comprised of two particles linked via an oligopeptide linkage that comprises a consensus sequence specific for the target protease. Cleavage of the sequence by the target protease can be detected visually or using various sensors, and the diagnostic results can be correlated with cancer prognosis.
Type:
Grant
Filed:
January 26, 2015
Date of Patent:
August 15, 2017
Assignee:
Kansas State University Research Foundation
Inventors:
Stefan H. Bossmann, Deryl L. Troyer, Matthew T. Basel
Abstract: The present invention relates to a microwave plasma deposition process and apparatus for producing diamond, preferably as single crystal diamond (SCD). The process and apparatus enables the production of multiple layers of the diamond by the use of an extending device to increase the length and the volume of a recess in a holder containing a SCD substrate as layers of diamond are deposited. The diamond is used for abrasives, cutting tools, gems, electronic substrates, heat sinks, electrochemical electrodes, windows for high power radiation and electron beams, and detectors.
Type:
Grant
Filed:
November 1, 2016
Date of Patent:
August 15, 2017
Assignees:
BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY, Fraunhofer USA
Inventors:
Jes Asmussen, Timothy A. Grotjohn, Donnie K. Reinhard, Rahul Ramamurti, M. Kagan Yaran, Thomas Schuelke, Michael Becker, David King
Abstract: The invention relates to intracellular lipid binding proteins that bind retinoids and/or dye ligands and that are modified to transmit or emit light at a variety of different wavelengths.
Type:
Grant
Filed:
October 15, 2015
Date of Patent:
August 15, 2017
Assignee:
Board of Trustees of Michigan State University
Inventors:
Babak Borhan, James Geiger, Wenjing Wang, Chrysoula Vasileiou, Kin Sing Lee, Tetyana Berbasova
Abstract: Nucleic acid vectors encoding light-gated cation-selective membrane channels, in particular channelrhodopsin-2 (Chop2), converted inner retinal neurons to photosensitive cells in photoreceptor-degenerated retina in an animal model. Such treatment restored visual perception and various aspects of vision. A method of restoring light sensitivity to a retina of a subject suffering from vision loss due to photoreceptor degeneration, as in retinitis pigmentosa or macular degeneration, is provided. The method comprises delivering to the subject by intravitreal or subretinal injection, the above nucleic acid vector which comprises an open reading frame encoding a rhodopsin, to which is operatively linked a promoter and transcriptional regulatory sequences, so that the nucleic acid is expressed in inner retinal neurons.
Type:
Grant
Filed:
May 21, 2013
Date of Patent:
August 15, 2017
Assignees:
Salus University, Wayne State University
Abstract: An object, such as a tumor from a breast lumpectomy, is placed into an object positioning device that can hold the object without deforming it. Such a device can include a container with a deformable foam, gel, or other material. The object positioning device is moved into an imaging device. Images of the object within the object positioning device are acquired by the imaging device. The acquired images are stored, processed, or output on a display device. Information about the spatial orientation of the object with respect to a reference object is preserved.
Type:
Grant
Filed:
May 6, 2013
Date of Patent:
August 15, 2017
Assignees:
University of Rochester, The Research Foundation for the State University of New York
Inventors:
Axel Wismueller, Andrzej Krol, Avice O'Connell
Abstract: In accordance with embodiments disclosed herein, there are provided methods and systems for implementing damage-and-resist-free laser patterning of dielectric films on textured silicon. For example, in one embodiment, such means include means for depositing a Silicon nitride (SiNx) or SiOx (silicon oxide) layer onto a crystalline silicon (c-Si) substrate by a Plasma Enhanced Chemical Vapor Deposition (PECVD) processing; depositing an amorphous silicon (a-Si) film on top of the SiNx or SiOx layer; patterning the a-Si film to define an etch mask for the SiNx or SiOx layer; removing the SiNx or SiOx layer via a Buffered Oxide Etch (BOE) chemical etch to expose the c-Si surface; removing the a-Si mask with a hydrogen plasma etch in a PECVD tool to prevent current loss from the mask; and plating the exposed c-Si surface with metal contacts. Other related embodiments are disclosed.
Type:
Grant
Filed:
September 29, 2016
Date of Patent:
August 15, 2017
Assignee:
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Abstract: This invention provides a method of promoting bone healing by locally administering a vanadium-based insulin mimetic agent to a patient in need thereof. The invention also provides a new use of insulin-mimetic vanadium compounds for manufacture of medicaments for accelerating bone-healing processes. In addition, the invention also encompasses a bone injury treatment kit suitable for localized administration of insulin-mimetic vanadium compounds or compositions thereof to a patient in need of such treatment.
Type:
Grant
Filed:
December 10, 2014
Date of Patent:
August 15, 2017
Assignee:
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Inventors:
Sheldon S. Lin, David N. Paglia, James P. O'Connor, Eric Breitbart, Joseph Benevenia
Abstract: The invention provides methods for enhancing the delivery of therapeutic compounds to the eye of a subject by administering plasmin or derivatives thereof and the therapeutic compounds to the eye.
Abstract: N-substituted sulfonylphenyl-5-mitrofuranyl-2-carboxamide derived compounds, which selectively activate the apoptotic, but not the adaptive arm, of the Unfolded Protein Response are provided as is their use in the treatment of diseases such as diabetes, Alzheimer's, Parkinson's, hemophilia, lysosomal storage diseases and cancer.
Type:
Grant
Filed:
June 18, 2013
Date of Patent:
August 15, 2017
Assignees:
University of Kansas, Sanford-Burnham Medical Research Institute, The Regents of the University of Michigan, Wayne State University
Inventors:
Jennifer E. Golden, Jeffrey Aube, Daniel P. Flaherty, Andrew M. Fribley, Randal J. Kaufman, Thomas D. Y. Chung, Anthony B. Pinkerton, Michael Pablo Hedrick
Abstract: CpG densities and sequence motifs that are characteristic of regions of DNA associated with epimutations and control of epimutations are provided. Such regions include, within approximately 400 (or fewer) base pairs, at least one, usually two, and preferably all three of the following features: i) a CpG density of 15% or less; ii) the presence of the sequence motif ATTTGTTTTTTCTTTTnT (SEQ ID NO: 1) where n is A, T, C or G, and statistically relevant variants thereof; and iii) the presence of the sequence motif GGGGGnGGGG (SEQ ID NO: 2), where n is A, T, C or G, and statistically relevant variants thereof.
Type:
Grant
Filed:
December 28, 2012
Date of Patent:
August 15, 2017
Assignee:
Washington State University
Inventors:
Michael K. Skinner, Carlos M. Guerrero-Bosagna
Abstract: The invention relates to novel luminescent compositions of matter containing a fluorophore, synthetic methods for making the compositions, macromolecular conjugates of the compositions, and the use of the compositions in various methods of detection. The invention also provides kits containing the compositions and their conjugates for use in the methods of detection.
Type:
Grant
Filed:
December 28, 2015
Date of Patent:
August 15, 2017
Assignees:
Rutgers, The State university of New Jersey, New Jersey Institute of Technology
Inventors:
Arkady Mustaev, Maxim Kozlov, Salvatore Marras, Lev Krasnoperov, Laura Wirpsza, Shyamala Pillai
Abstract: A method for using a location-based service while preserving anonymity includes receiving a location associated with a mobile node, receiving an anonymity level associated with the mobile node, computing a region containing the location of the mobile node and a number of footprints based on the anonymity level, wherein each of the footprints from a different user, and providing the region to a location-based service to thereby preserve anonymity of the mobile node. A method also allow a mobile device or its user to specify the anonymity level by selecting a public region consistent with a user's feelings towards desired privacy.
Type:
Grant
Filed:
December 21, 2015
Date of Patent:
August 15, 2017
Assignee:
Iowa State University Research Foundation, Inc.
Abstract: An endoscopic imaging system is disclosed that includes an endoscope having a first channel and a second channel, a high-power, multi-wavelength LED array, a digital micro-mirror device that receives light directed from the high-power, multi-wavelength LED array and generates spatial frequency patterns, and dichroic mirror that separates reflectance and fluorescence images.
Abstract: The invention relates to compositions and methods for diagnosing and treating hyperproliferative disorders using ligands which specifically recognize the hypusine and/or folate binding region of mature eukaryotic translation initiation factor 5A (hypusine-containing eIF-5A). The invention further relates to methods of identifying molecules which displace immunoreagents binding to mature eIF-5A. Such agents are useful for treating hyperproliferative disorders.
Type:
Application
Filed:
January 2, 2014
Publication date:
August 10, 2017
Applicant:
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Inventors:
Hartmut M. Hanauske-Abel, Myung-Hee Park, Edith C. Wolff, Debra Sheldon-Heller, Bernadette M. Cracchiolo, Anthony Popowicz, Paul M. Clement
Abstract: The present invention features compositions that include a fungal glucosylceramide (GlcCer) purified from a non-pathogenic fungus (e.g., Candida utilis) and, optionally, an adjuvant. The invention also features methods of treating a patient who has a fungal disease and methods of preventing a fungal disease in a subject by administration of these compositions. Also within the scope of the invention are methods of formulating a fungal vaccine by: (a) providing a fungal glucosylceramide isolated from a non-pathogenic fungus; and (b) combining the fungal glucosylceramide with an adjuvant in a physiologically acceptable excipient.
Type:
Application
Filed:
September 30, 2015
Publication date:
August 10, 2017
Applicants:
KOHJIN LIFE SCIENCES CO., LTD., THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Inventors:
Maurizio DEL POETA, Visesato MOR, Toshiya SATO, Tomohiro NAKAGAWA